Rapamycin-encapsulated costimulatory ICOS/CD40L-bispecific nanoparticles restrict pathogenic helper T-B-cell interactions while in situ suppressing mTOR for lupus treatment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rapamycin-encapsulated costimulatory ICOS/CD40L-bispecific nanoparticles restrict pathogenic helper T-B-cell interactions while in situ suppressing mTOR for lupus treatment
Authors
Keywords
-
Journal
BIOMATERIALS
Volume 289, Issue -, Pages 121766
Publisher
Elsevier BV
Online
2022-08-31
DOI
10.1016/j.biomaterials.2022.121766
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells
- (2022) Edward Seung et al. NATURE
- Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus
- (2022) Yusuke Takeshima et al. ANNALS OF THE RHEUMATIC DISEASES
- Bispecific antibodies in oncology
- (2022) Arman Esfandiari et al. NATURE REVIEWS DRUG DISCOVERY
- Improvement of renal and non-renal SLE outcome measures on sirolimus therapy – A 21-year follow-up study of 73 patients
- (2021) Paramarajan Piranavan et al. CLINICAL IMMUNOLOGY
- Therapeutic mTOR blockade in systemic autoimmunity: Implications for antiviral immunity and extension of lifespan
- (2021) Christian Geier et al. AUTOIMMUNITY REVIEWS
- Distinct roles of ICOS and CD40L in human T-B cell adhesion and antibody production
- (2021) Zhicui Liu et al. CELLULAR IMMUNOLOGY
- T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy
- (2020) Amir Sharabi et al. Nature Reviews Rheumatology
- Lupus nephritis
- (2020) Hans-Joachim Anders et al. Nature Reviews Disease Primers
- Metabolic determinants of lupus pathogenesis
- (2020) Xiangyu Teng et al. IMMUNOLOGICAL REVIEWS
- Autoimmunity and organ damage in systemic lupus erythematosus
- (2020) George C. Tsokos NATURE IMMUNOLOGY
- Systemic Lupus Erythematosus
- (2020) Marianthi Kiriakidou et al. ANNALS OF INTERNAL MEDICINE
- Targeting co-stimulatory molecules in autoimmune disease
- (2020) Natalie M. Edner et al. NATURE REVIEWS DRUG DISCOVERY
- Leveraging Heterogeneity in Systemic Lupus Erythematosus for New Therapies
- (2020) Marilyn E. Allen et al. TRENDS IN MOLECULAR MEDICINE
- T FH cells in bystander and cognate interactions with B cells
- (2019) Zurong Wan et al. IMMUNOLOGICAL REVIEWS
- 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
- (2019) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- Bispecific antibodies: a mechanistic review of the pipeline
- (2019) Aran F. Labrijn et al. NATURE REVIEWS DRUG DISCOVERY
- New therapies for systemic lupus erythematosus — past imperfect, future tense
- (2019) Grainne Murphy et al. Nature Reviews Rheumatology
- Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial
- (2018) Zhi-Wei Lai et al. LANCET
- Metabolism as a Target for Modulation in Autoimmune Diseases
- (2018) Nick Huang et al. TRENDS IN IMMUNOLOGY
- Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity
- (2018) Yuan Zhang et al. Nature Communications
- Blockade of Treg Cell Differentiation and Function by the Interleukin-21-Mechanistic Target of Rapamycin Axis Via Suppression of Autophagy in Patients With Systemic Lupus Erythematosus
- (2018) Hiroshi Kato et al. Arthritis & Rheumatology
- Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond
- (2018) Jodi L. Karnell et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival
- (2018) Baharak Bahmani et al. JOURNAL OF CLINICAL INVESTIGATION
- New therapeutic strategies in systemic lupus erythematosus management
- (2018) Mariele Gatto et al. Nature Reviews Rheumatology
- Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy
- (2017) Hengfeng Yuan et al. Nature Nanotechnology
- Next generation antibody drugs: pursuit of the 'high-hanging fruit'
- (2017) Paul J. Carter et al. NATURE REVIEWS DRUG DISCOVERY
- T follicular helper (Tfh) cells in lupus: Activation and involvement in SLE pathogenesis
- (2016) Patrick Blanco et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Loss of Immune Tolerance Is Controlled by ICOS in Sle1 Mice
- (2016) Nanette Mittereder et al. JOURNAL OF IMMUNOLOGY
- Beyond pan-B-cell-directed therapy — new avenues and insights into the pathogenesis of SLE
- (2016) Thomas Dörner et al. Nature Reviews Rheumatology
- T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity
- (2015) Vaishali R. Moulton et al. JOURNAL OF CLINICAL INVESTIGATION
- CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study
- (2015) Anthony Shock et al. ARTHRITIS RESEARCH & THERAPY
- T–B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction
- (2014) Dan Liu et al. NATURE
- HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE
- (2013) Tiffany N Caza et al. ANNALS OF THE RHEUMATIC DISEASES
- The Spleen in Local and Systemic Regulation of Immunity
- (2013) Vincenzo Bronte et al. IMMUNITY
- ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4+T cells by plasmacytoid dendritic cells
- (2013) Julien Faget et al. OncoImmunology
- Development of macromolecular prodrug for rheumatoid arthritis
- (2012) Fang Yuan et al. ADVANCED DRUG DELIVERY REVIEWS
- Plasmacytoid Dendritic Cells Promote Immunosuppression in Ovarian Cancer via ICOS Costimulation of Foxp3+ T-Regulatory Cells
- (2012) C. Conrad et al. CANCER RESEARCH
- The development and function of follicular helper T cells in immune responses
- (2012) Maogen Chen et al. Cellular & Molecular Immunology
- IL-6: Regulator of Treg/Th17 balance
- (2010) Akihiro Kimura et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- CD28 and inducible costimulator (ICOS) signalling can sustain CD154 expression on activated T cells
- (2008) Denise A. Kaminski et al. IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now